Therapeutic Strategies Against COVID-19 and Structural Characterization of SARS-CoV-2: A Review
The novel coronavirus, SARS-CoV-2, or 2019-nCoV, which originated in Wuhan, Hubei province, China in December 2019, is a grave threat to public health worldwide. A total of 3,672,238 confirmed cases of coronavirus disease 2019 (COVID-19) and 254,045 deaths were reported globally up to May 7, 2020. H...
Main Authors: | Gi Uk Jeong, Hanra Song, Gun Young Yoon, Doyoun Kim, Young-Chan Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.01723/full |
Similar Items
-
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01) -
SARS-CoV-2 and the Use of Chloroquine as an Antiviral Treatment
by: Mathieu E. Rebeaud, et al.
Published: (2020-04-01) -
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
by: Khan Sharun, et al.
Published: (2020-05-01) -
Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01) -
Comparing and Contrasting MERS, SARS-CoV, and SARS-CoV-2: Prevention, Transmission, Management, and Vaccine Development
by: Mohammad Oves, et al.
Published: (2020-11-01)